Efficacy of combination treatment using YHO-1701, an orally active STAT3 inhibitor, with molecular-targeted agents on cancer cell linesKeisuke Taniguchi, Akira Asai|Research Square|2020Cited by 1
CD34+CD31+ immature myeloid cells (IMC) as an inhibitor cell on the production of antimicrobial peptide: II. Glycyrrhizin inhibits IMC suppressor cell activities (89.27)Shohei Yoshida, Fujio Suzuki, Akihito Inatsu et al.|The Journal of Immunology|2010Cited by 0